Scientific Advisors
back to LION bioscience home
SitemapPrintable version of this documentContact LIONZur deutschen Version dieses Dokuments LION bioscience AG
Company
Business Model
Global Organisation
Executive Management
Senior Management
Supervisory Board
Scientific Advisors
Animation: Modern Drug Discovery
History
Collaborating Partners
Customers
Events
 

© 2004 LION bioscience AG
Disclaimer
Imprint/Contact
Contact Webmaster
Scientific Advisors
 
LION maintains close connections to the worldwide scientific community to stay at the leading edge of scientific developments. Our scientific advisors are: Science

Dr. Georg Casari
Life Science Informatics Research, Heidelberg, CellZome

Prof. Dr. Franz Günthner
CIS, Munich, ELEXIR GmbH, Munich, Germany

Alan Katritzky, Ph.D.
University of Florida, USA

Albert Meyers, Ph.D.
Colorado State University, USA

Dr. Christopher Ponting
University of Oxford, Oxford, U.K.

Prof. Dr. Burkhard Rost
Columbia University Bioinformatics Centre, New York City, USA

Dr. Alfonso Valencia
Universidad Complutense de Madrid, Madrid, Spain

Dr. Reinhard Schneider

Dr. Jan Mous


CV's of our scientific advisors

Dr. Georg Casari
Life Science Informatics Research, is a co-founder of LION and has been with the company from March 1997 to April 2002. During his tenure as a staff scientist at the EMBL (European Molecular Biology Laboratory), Dr. Casari worked in the area of high-throughput sequence analysis. He focused on computational analysis of protein structures during his post-doctoral fellowship at Salzburg University, Austria. Dr. Casari received his Ph.D. at the IMP (Institute for Molecular Pathology) in Vienna, Austria.

Prof. Dr. Franz Günthner
is the director of the CIS in Munich, which he created in 1990 as part of the Ludwig-Maximilians-University of Munich. He recently founded the "ELEXIR Sprach- und Informationstechnologie GmbH". He obtained his Ph.D. in linguistics from the University of Paris) and his habilitation in theoretical linguistics from the University of Stuttgart). Dr Günthner's main areas of research are formal semantics, philosophical logic and computational linguistics. He has published several books and over 70 papers in these areas. Since 1991 he has lead extensive research in the construction of electronic dictionaries in several languages. In the past years he has developed innovative solutions for well-known companies such as Elsevier, Springer-Verlag, Alta Vista and Real Names.

Alan Katritzky, Ph.D.
Dr. Katritzky is a Kenan Professor and the director for heterocyclic compounds in the Department of Chemistry at the University of Florida. Dr. Katritzky received his Ph.D. from the University of Cambridge in 1963 and is a member of the Royal Society of London. He is an internationally recognized expert in all aspects of synthetic heterocyclic chemistry and has received numerous international awards for his work. He has authored or co-authored over 1,500 scientific publications, has written numerous books and currently serves on 13 editorial boards.

Albert Meyers, Ph.D.
Dr. Meyers is the Distinguished University and John K. Stille Professor at Colorado State University. Dr. Meyers received his Ph.D. from New York University in 1957. He is internationally recognized for his work in synthetic heterocycles and small molecule organic compounds. Dr. Meyers has authored more than 375 scientific publications in the area of small molecule and heterocyclic synthesis. He has received numerous awards and was elected to the National Academy of Sciences in 1994.

Dr. Christopher Ponting
Dr. Ponting is a member of the MRC Functional Genetics Unit of the department of Human Anatomy and Genetics of the University of Oxford. With a Ph.D. from the University of Oxford, Dr. Ponting's scientific interests include re-casting genomic and proteomic information in order to address issues of evolution and biological function.

Dr. Burkhard Rost
is a professor in the Department of Biochemistry and Molecular Biophysics at Columbia University in New York. Dr. Rost contributed to the most widely used software programs for protein structural analysis. He also helped to launch "Predict Protein", an Internet service for protein structure prediction. Dr. Rost has been involved in numerous research programs at leading institutions such as Princeton University, the EMBL and the Massachusetts Institute of Technology (MIT). Dr. Rost received a Bachelor degree in history and philosophy and a Master degree in physics from Heidelberg University. He holds a Ph.D. in physics from the Institute for Theoretical Physics of the Ruprecht-Karl University in Heidelberg.

Dr. Alfonso Valencia
is a senior scientist at the National Centre for Biotechnology in the Spanish Research Council (CNB - CSIC) in Madrid, Spain. He has been working in bioinformatics for the last 12 years in the development and application of new methods in the fields of protein structure prediction, genome analysis and practical protein engineering. After a five-year post-doctoral position at the EMBL, Heidelberg he founded a new group a the CNB-CSIC in Madrid. Currently he is the co-ordinator of the Spanish Bioinformatics Network, founder of the International Society for Computational Biology (ISCB), member of the editorial board of Bioinformatics and advisor of several international scientific committees.

Dr. Reinhard Schneider
is a co-founder of LION and has been with the company until February 2003 as Chief Information officer. As a scientist in the biocomputing department at the EMBL (European Molecular Biology Laboratory, Heidelberg), Dr. Schneider studied various aspects of protein structure prediction and sequence alignment as well as the development of large scale automated sequence analysis and the use of massive parallel computers in biology. Dr. Schneider studied biology in Aachen and Heidelberg and received his Ph.D. in biology at the University of Heidelberg, Germany.

Dr. Jan Mous
served as CSO of LION until the end of 2002. Dr. Mous has both extensive scientific as well as managerial experience which he gained working at Hoffmann-La Roche Ltd. in Basel, Switzerland starting in 1985. Dr. Mous served as the global head of genomics technology platform of Hoffman-La Roche after being head of genomics research and deputy head of central nervous system research. Before that, Dr. Mous was head of Roche's gene technology and genomics. Prior to that appointment he conducted various research projects, including exploratory research projects for drug target identification in different areas. Dr. Mous holds a Ph.D. in biochemistry from the University of Leuven in Belgium and the "venia docendi" from the University of Basel, Switzerland.